Introduction

No man, tissue, cell, organelle, or gene is an island, entire of itself; each is a piece of the whole, a part of the galloping beast and a single voice in a living choir.
An evolutionary biochemist's translation (with apologies to John Donne) from Devotions upon Emergent Occasions, 1624 The organismal effects of mitochondrial dysfunction spring from ruptures in an ancient alliance. Mitochondria were once free-living bacteria that merged their metabolic machinery with archaebacteria to produce a co-operative metabolism that became the first eukaryotic cell (Margulis, 1970 (Margulis, , 1992 Gray et al, 1999) . Today, nearly 2.5 billion years after that alliance was forged, all multicellular animal life is strictly dependent on the maintenance of a fluid dialectic between mitochondria and host cell. This dialectic regulates the function of mitochondria in ways that enable cells to become metabolically specialized and interdependent. Co-operative metabolism is the foundation for tissue differentiation. Adjoining cells are locked in symbiosis when each produces at least one product the other needs to survive. Metabolic co-operation underlies both the radiation and diversity of animal body plans during evolutionary time, and during the development of embryo to adult. Mitochondrial specialization is a natural consequence of tissue-specific transcription. Mitochondrial biogenesis requires the expression of -3000 genes (Wallace, 1992) . Only 37 RNA and peptide transcripts are encoded by human mitochondrial DNA (mtDNA). This is <2% (37 of 3000 = 1.2%) of the genetic information required. In the genetic economy of the endosymbiont, >98% of the genes needed for mitochondrial biogenesis must be transcribed in the host cell nucleus and the products must be imported into the organelles. The biochemical palette used by mitochondria is exceedingly rich, yet largely unemphasized in traditional didactic presentations of mitochondrial function. To understand the scope of mitochondrial disease, one needs to push beyond the 'energy factory' stereotype and the chauvinism of single mitochondrial electron transport chains. Indeed, there is a fertile pluralism of electron transport chains in mitochondria. Only one of these chains stores energy as a proton chemiosmotic gradient that leads to ATP synthesis via oxidative phosphorylation (Figure 1 ). The others also consume oxygen and make water, but they differ from the oxidative phosphorylation sequence in that they use electrons to form and break chemical bonds in the biosynthesis of numerous cell-specific products. Figure 2 illustrates one example: the synthesis of steroid hormones (see also Donohoue et al, 1995) . ATP is just one of a myriad of products that specialized cells require their mitochondria to assemble. Table I is an incomplete but useful summary of some of the tissue-specific biosynthetic functions of mitochondria. Some of these are linked to electron transport. Others are not. Structural and biochemical diversity, tissue-specificity, and developmental control of mitochondrial functions are the keys to understanding the dizzying array of symptoms characteristic of inherited mitochondrial disease and many of the more complex disorders of ageing.
Solid state biochemistry
Mitochondria are solid state bioreactors in which biochemical transformations are conducted in and on surfaces. The geometric packing of proteins within the mitochondrial
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Figure 2. Mitochondrial electron transport chain used for steroid hormone synthesis in the adrenal cortex, ovaries, and testis. matrix, and in and on mitochondrial membranes, is highly ordered. Protein concentrations in the matrix approach 500 mg/ml; reflecting a 50% hydration state (similar to the protein packing observed in a crystal of trypsin). Like the ordered arrangement of American football players at the scrimmage line before the ball is snapped, mitochondrial proteins must be assembled in the correct relative positions in order to receive reactants and convey products to the next enzyme in the metabolic chain (Srere, 1985 (Srere, , 1987 . Nature dispensed with solution biochemistry as catalytically cumbersome >3.8 billion years ago, with the emergence of the first bacterial cell. Reliance on Brownian motion in three-dimensional space was, we believe, unacceptably slow and provided limited opportunities for tight control of metabolic flux. Growth and differentiation could not evolve until surface catalysis emerged and an autopoietic metabolism could ignite.
The tight geometric packing of mitochondrial proteins creates a de-facto mechanism for fine tuning the catalytic efficiency of individual organelles. Volume regulation of surface catalysis is an important mechanism of biochemical control. Imagine the inner surface of a balloon decorated with small styrofoam spheres of all shapes, sizes, and colours. Under native conditions, all the spheres are optimally distributed and just touching. As the balloon is blown up, its volume increases and the spheres move away from one another. The proteins in swollen mitochondria are likewise mutually separated. Like damping rods in a nuclear fission reactor, water molecules fill the gaps created by the separation of previously adjoining proteins. This slows the flux of reactants and products in the affected metabolic chains. Mitochondrial swelling can take place over minutes to hours in response to a variety of environmental stimuli. Under certain circumstances, this can lead to a loss of mitochondrial transmembrane potential, cytochrome C release to the cytoplasm, and programmed cell death (Kluck et al, 1997) . Over-expression of certain proteins, e.g. bcl-x L , can prevent this swelling and prevent apoptosis in certain cell types (Vander Heiden et al, 1997) .
Imagine the time it takes a drop (50 JLLI) of red oil, which has a density equal to that of water, to reach the opposite side of a swimming pool (2X10X25 m; 5X10 5 1) by a random walk in three-dimensional space. The volume ratio of the dye to the pool is l:10 10 . This is about the same volume ratio of -100 proteins with hydration spheres of 5 nm, magically conducting themselves through the cell membrane, past actin filaments, intermediate filaments, microtubules, rough endoplasmic reticulum (ER), smooth ER, and the Golgi, to the eccentrically located nucleus of a 50 |im diameter hepatocyte. Even with signal transduction and amplification via second messengers, this is a kinetically herculean task. Now imagine the same drop of red dye conducted on a one-dimensional, hydrophobic filament that is continuously moving toward the other side of the pool. Max Delbriick developed a mathematical demonstration of how dimensional reduction in biological systems along sheets (two-dimensions) and rods (one-dimension) could accelerate signal transduction by several orders of magnitude (Delbriick, 1968) . Evolution made this discovery when life first began: the chemistry of living cells is conducted in sheets and rods (membranes and the cytoskeleton), not in solution.
Cellular tensegrity and mechanotransduction are concepts that help to explain biochemical function in terms of cell shape (Ingber, 1993; Wang et al, 1993) . Mitochondria are intimately associated with all elements of the cytoskeleton at different times throughout the life of different cell types in different tissues (Soltys and Gupta, 1992; Rappaport et al, 1998) . Because biochemical resources are not evenly distributed within the cell, organellar position and juxtaposition with the Golgi, ER, lysosomes, peroxisomes, and the nucleus have dramatic effects on mitochondrial function. Subcellular redistribution of mitochondria controls the flow of substrates and products through the organelles according to cellular need. Phenomena such as axoplasmic transport of mitochondria to nerve terminals (Okada et al, 1995) and the perinuclear accumulation of mitochondria after heat shock (Collier et al, 1993) help illustrate differences in mitochondrial function that occur with differences in subcellular location. Changes in mitochondrial respiration accompany these simple changes in address (or the subcellular address of neighbours) of mitochondria within the cell (Saks et al, 1995) . The proteins responsible for the redistribution of mitochondria within mammalian cells are related to the kinesins, intermediate filament-, microtubule-and actinassociated proteins that have been, and are being, identified in simple cell model systems (Yaffe, 1999) .
Structural diversity of mitochondria
Mitochondria (Figure 3 ) occur in many sizes and shapes, with inner mitochondrial membranes (cristae) that take many different patterns, depending on the membrane-bound metabolism called for. As mentioned earlier, 98% of mitochondrial function (in terms of gene number) is determined by the genetic program of the host cell via cell-specific nuclear transcription. Only 2% is determined by mtDNA. There are roughly 250 different cell types in the human body plan (Kauffman, 1991) , each with its own unique pattern of gene expression, regulated by nuclear transcription. Correspondingly, there are probably 250 unique types of mitochondria, each tailored by unique patterns of nuclear gene transcription to perform suites of metabolic functions that are regulated both developmentally and tissuespecifically. Function follows form.
Tissue-specific and developmental regulation of mitochondria mtDNA is amplified in some, but not all, tissues after birth. In a study that compared the mtDNA content with developmental age in a number of human tissues, Heerdt and Augenlicht (1990) showed that by 22-32 weeks gestational age the mtDNA content of marrow, peripheral blood leukocytes, spleen, and adrenal glands had already achieved the adult level. However, there was a 2-3-fold amplification of mtDNA between 32 weeks gestation and the adult in liver, kidney and muscle. The brain is likely to show similar mtDNA amplification after birth, although it was not specifically addressed in this study.
Other workers have also observed the agedependent amplification of skeletal muscle mtDNA (Poulton et ai, 1995) . There is a rapid, 3-5-fold increase in the second and third trimesters of pregnancy, then a more gradual, additional 3-fold amplification which may not be complete until around the time of puberty. Liver mitochondrial respiratory capacities increase two-fold in the first 2 h after birth in the rat, achieving 50% of the adult value (Valcarce, 1988) . This is accompanied by a marked reduction in mitochondrial volume and an increase in available adenine nucleotides, in keeping with the concept of volume regulation of surface catalysis discussed above. Pyruvate oxidation in skeletal muscle of the rat increases more slowly and does not achieve the adult value until about the time of reproductive maturity (Sperl et al, 1992) . This is consistent with the notion that maximum respiratory potential in skeletal muscle is not achieved until the adult level of mtDNA is reached, around the time of puberty.
Biotic potential -why cells growing in vitro are different
Why are cells growing in culture different to cells in tissues? Perhaps the most fundamental differences are cellular address (location) and selection. Cells growing in culture have continuously changing neighbours, whereas cells in tissues have stable neighbours. Growing cells must each remain biochemically selfreliant and homogeneous in order to provide the self-renewing resource that is so experimentally powerful. Growing cells with these attributes undergo intense Darwinian selection in the laboratory. Differentiated cells that exit the cell cycle, or senesce as they exceed the Hayflick limit, are difficult to work with. They are continuously being diluted by the biotic potential of their dividing neighbours. Stationary cells in tissues, on the other hand, are differentiated and naturally heterogeneous. Metabolic co-operation emerges spontaneously as cells reduce the number of genes expressed. Only communities of cells with complementary patterns of nutritional needs and export products can survive in steady state throughout the life of the organism. About 0.1-1% of hepatocytes make albumin: the great majority of liver cells do not. This pattern of heterogeneous expression of differentiated, non-housekeeping gene products is characteristic of every tissue in the body (and cannot be replicated easily in cell or tissue culture). Differential expression of proteins within liver mitochondria also occurs. Only the mitochondria in the relatively oxygen-poor, perivenous hepatocytes contain ornithine aminotransferase (OAT), whereas only the mitochondria in the oxygen-rich, periarteriolar hepatocytes express the urea cycle enzyme ornithine transcarbamylase (Figure 4) (Valle and Simell, 1995) . A similar differential phenomenon can be seen in skeletal muscle. A lactate importer is expressed on the surface of aerobic, type I skeletal muscle fibres and high levels of succinate dehydrogenase (SDH) are found in their mitochondria (Garcia et al, 1994) . Adjoining, glycolytic, type II muscle fibres do not express the lactate importer and express low levels of mitochondrial SDH. Like all tissues, muscle is a mosaic of functionally interdependent cells. Brain is the most complex mosaic of any tissue. How do cells of the growing embryo develop into tissues? A fundamental answer to this question has been the focus of intense and richly productive research for over a century. However, a numerical framework can be sketched that will help to understand why tissues appear to be made of cells that are metabolically interdependent. In genetic terms, the cells of terminally differentiated tissues are complementary auxotrophs, unable to synthesize the full suite of molecules required for survival. In contrast, the mRNA repertoire stored and expressed by the fertilized sea urchin oocyte approaches 40 000 genes, virtually the full repertoire of genes encoded by the nuclear DNA of this uniquely versatile and experimentally useful organism (Galau etal, 1976; Hough-Evans etal, 1977) .
The oocyte expresses the highest fraction of nuclear genes of any cell type. It also has the largest number of mitochondria of any cell. The mammalian oocyte contains -200 000 mitochondria (Piko and Matsumoto, 1976) , with -1-2 copies of mtDNA per organelle (Michaels etal., 1982) . Somatic cells typically contain 1000-2000 mitochondria and 3-10 copies of mtDNA per organelle (Michaels et al, 1982; Piko and Taylor, 1987) . This is just 1% of the level in primary oocytes. Therefore, the process of embryogenesis pro-duces cells that express RNA from progressively smaller subsets of their nuclear DNA, and contain progressively fewer mitochondria and mtDNA, although the copy number of mtDNA per organelle increases 3-5-fold with differentiation after gastrulation. In the human, expression of nearly 100 000 mRNAs in the oocyte must be pruned to the 10 000-15 000 mRNAs characteristic of terminally differentiated cells. As cells differentiate, therefore, genes are inexorably shut down, and pluripotentiality is progressively restricted.
As genes are shut down, cells become auxotrophs for certain nutrients. They can no longer sustain the reducing intracellular environment in which most of the free electrons are routed to the biosynthesis of polymers (polypeptides, membrane lipids, glycogen, DNA, etc) that were needed to increase biomass during mitosis. Differentiating cells exit the cell cycle and shift from a perpetual growth (reducing) metabolism to a maintenance (oxidizing) metabolism. In the stationary phase of life, cell biomass is no longer increasing. In order to maintain a fixed biomass, electrons that were once liberated for polymer synthesis are shifted away from bond-formation. These electrons are used to reduce oxygen to water in the mitochondrial electron transport chain. Combustion becomes more complete, and energy production is more efficient. The price of efficiency is metabolic co-operation (comparable to the insight Adam Smith made in his Wealth of Nations). In a system made up of parts, there is no qualitative advantage to the assembly of identical subunits of generalists: it only pays to co-operate among specialists. Industrial and biochemical assembly lines have much in common. Generalists, independence, growth and specialists, co-operation, and production are two sides of the same coin.
The primacy of diagnosis
In medicine, accurate diagnosis is the essential first step in the care of the patient. Prognosis cannot be assigned, therapies cannot be effectively tailored, and accurate genetic counselling cannot be offered until a pathogenetic diagnosis is established. The complexity of mitochondrial disease particularly mandates a methodical approach to diagnosis. Table II reports a 7-point work-up for mitochondrial disease. It provides the foundation for diagnosis of a number of established mitochondrial disorders and provides clues for further, more comprehensive studies of disorders that
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are not yet fully characterized.
Organismal effects of mitochondrial dysfunction
The English neurologist, John Hughlings Jackson, taught his students, 'The study of the causes of things must begin with the study of things caused'. We developed the mitochondrial clinical assessment scale (MCAS) to catalogue the patterns of clinical and biochemical features caused by mitochondrial disease (a full description of this scale and its implementation will be described elsewhere) (R.K. Naviaux and K.A.McGowan, unpublished data) . The mitochondrial clinical assessment scale (MCAS) is an organ-system survey of the pattern and severity of disease resulting from mitochondrial dysfunction. The MCAS-I had 23 organ systems divided into 55 categories, arranged roughly in anatomical order, from head to toe. Each of the categories had a three point grading scale: 0 = no abnormality was detected; 1 = moderate dysfunction; 2 = abnormalities that were not corrected by treatment. The maximum possible MCAS-I score was 110 (55 categories X2 points/category). Healthy subjects have a score of 0. Over 300 inpatients were referred and evaluated for possible mitochondrial disease from 1994 to 1998 at the Mitochondrial and Metabolic Disease Center, University of California, San Diego School of Medicine. All of these patients received a comprehensive, elective, 4-day metabolic evaluation in the hospital. Of these patients, 40 were found to have forms of mitochondrial disease that led to unstimulated blood or cerebrospinal fluid lactic acid levels >3 mmol/1; half of these patients with lactic acidaemia were under the age of 5 years. The median age was 7 years (range 0.5-53). Table  III summarizes the mitochondrial diagnoses discovered in this group. Each of these 40 patients was scored using the MCAS-I. The scores were normally distributed with a mean of 32.7 and a SD of 7.0 (range 21-50). MCAS-I scores for patients aged >5 years were not significantly different from the scores of patients aged <5 years. Analysis of these data permitted us to identify and rank-order the most frequently affected organ systems and laboratory abnormalities. Table IV summarizes these data. The traditional standards for making a diagnosis of mitochondrial disease lie with biochemical, enzymological and molecular studies (Walker et al., 1996; Bernier et al., 1998) and we employed these. Thus, by definition, 40 of 40 patients in our series had abnormalities in one or more of these studies (Table IV) . The most commonly affected organ was the brain. About 75% of patients had some degree of endocrine dysfunction, the most common manifestation of which was subclinical insulin resistance, seen as an exaggerated hyperglycaemic and hyperinsulinaemic response to a standardized glucose load. Only two of our 10 patients with the MELAS (mitochondrial encephalomyopathy, lactic acidaemia and stroke-like episodes) (A3243G) mutation had frank diabetes mellitus; both type I and type II diabetes were observed with this mutation.
Some of the organ systems that were less frequently observed to be abnormal in our series were simply the result of lack of ascertainment. For example, we evaluated only one child with Pearson Marrow Pancreas syndrome (PMPS) ( Table III) . This was the only patient with evidence of exocrine pancreas deficiency. This example serves as a warning, that a simple tally of organ systems affected in a population of mitochondrial disease is only the first step toward understanding 'the study of things caused', as John Hughlings Jackson put it. To begin a study 'of the causes of things' one needs to organize the patterns of abnormalities associated with specific mitochondrial disease. We call these patterns the diagnostic spectra of mitochondrial disease.
The infection connection
Of particular note is an observation that does not receive sufficient emphasis in the literature of mitochondrial disease: the frequency of recurrent infections. Two thirds of the patients in our series (25 out of 40) had histories of recurrent upper respiratory or genito-urinary tract infections. The importance of infection in mitochondrial disease should not be underestimated. The majority of clinically important neurodegenerative episodes associated with mitochondrial diseases occur during or in the week following an otherwise trivial infection, e.g. otitis media, sinusitis, gastroenteritis, or coryza. The mechanism for neurodegeneration in this period is not related to catabolic stress: patients are often recovering from their infections and have good nutrient intakes when ataxia, dysphagia, aphasia, or encephalopathy supervene. The tight coupling between mitochondrial failure and infection could relate to the involvement of host defence cytokines and mitochondria in apoptosis (Green and Reed, 1998) , but the precise mechanisms await further investigation.
Developing diagnostic spectra of mitochondrial disease
By displaying the results of the MCAS-I as a bar graph with 55 categories, it became apparent that each patient's unique pattern of clinical and laboratory abnormalities took on the quality of a spectrum with 55 channels. This was reminiscent of chemical ion spectr/a observed in the analysis of organic acids by mass spectrometry. We arrayed the MCAS-I spectra of patients with the same molecular diagnosis and summed them to produce a composite spectrum that revealed the similarities and differences among the diseases. This is illustrated in Figure 5 for MELAS. Figure 6 compares the composite MCAS-I spectra of 10 patients with MELAS, five with COX (cytochrome C oxidase) deficiency and Leigh syndrome, and five with Complex I deficiency and Leigh syndrome. The numerical codes that corresponded to features observed in 80-100% of the patients with each diagnosis were listed as 'MCAS-I spectra' on the right of Figure 6 . Exclusion criteria also proved useful and were listed with the numerical codes. An important conclusion from this study was that there is considerable overlap in the phenotypes of mitochondrial disease. Even so, discriminant patterns emerged that were useful in developing both quantitative and qualitative instruments for characterizing mitochondrial disease. A total of 55 characters were scored for each patient and arrayed on the jc-axis to yield a spectrum. Spectra were summed to produce the composite MELAS spectrum shown at the bottom.
Figures 5 and 6 are meant to convey the principles behind the MCAS-I analysis without belabouring the details of each organ system analysed. The scoring of a single patient takes ~5 min, once all the relevant clinical and biochemical data are assembled. Our hope is that interest in the development of clinically useful diagnostic spectra of mitochondrial disease will foster the use of the MCAS-II in medical centres around the world that care for patients these disorders. By combining the clinical experiences of many centres, it will be possible to identify distinctive patterns that exist. These will guide both clinicians and scientists. Clinicians will have a strong, quantitative resource to guide them in diagnosis and prognosis. Scientists will develop a more complete knowledge of the manifestations of mitochondrial disease, many of which are completely unpredicted by current knowledge of mitochondrial biology. This will help drive new investigations into the role of mitochondria in evolution, development, ageing, and disease. The MCAS-II scoring forms are available upon request from the authors. 
Conclusions
Mitochondrial biology has a rich and noble history dating back to 1888, when Kolliker first teased the organelles from insect flight muscle (Lehninger, 1965) . Exactly a century later the discovery of the first mtDNA mutations in human disease was made (Holt et al, 1988; Wallace et al, 1988; Zeviani et al, 1988) and helped renew interest in the biology of these fascinating organelles. Mitochondrial medicine is now one of the fastest growing fields in all of human biology. It is poised to become a bridging discipline that in the coming years will illuminate previously non-apparent connections between subspecialties of medicine and biology. This review has emphasized the tissuespecific differences in mitochondrial form and function. Disturbances in mitochondrial function lead to selective abnormalities in organ systems that are explainable in retrospect, but which cannot be predicted on the basis of current paradigms. Every year sees the publication of new observations in mitochondrial replication and biology that defy the explanatory power of current theory. This represents a growing tide of anomaly in mitochondrial biology. When accepted theory lacks predictive power, and the catalogue of anomalies grows beyond theory's embrace, then fundamental surprises and novel insights are inevitable.
